Zinc Finger Protein 326 (ZNF326) activators are a diverse set of compounds that enhance the function of ZNF326 through various biochemical mechanisms. ZNF326 is a transcription factor that typically binds to DNA and regulates the expression of numerous genes. The activators of ZNF326 influence its activity by facilitating its DNA-binding capability and stabilizing the transcriptional machinery. For example, certain small molecule enhancers may directly interact with the DNA-binding domain of ZNF326, promoting a conformational change that results in higher affinity for DNA targets. This enhancement of DNA binding by ZNF326 activators ensures a more robust transcriptional response to physiological signals. Additionally, post-translational modifications of ZNF326 can be influenced by activators that modulate the activity of kinases and phosphatases. Phosphorylation state-specific activators can thus enhance ZNF326 activity by promoting its interaction with co-activators or by protecting it from degradative pathways, ensuring its sustained presence in the nucleus and its ongoing participation in gene regulation.
The functional capacity of ZNF326 is also indirectly augmented by molecules that modulate the cellular milieu in which ZNF326 operates. Certain activators may increase the local concentration of co-factors required for the full transcriptional activity of ZNF326. Moreover, compounds that alter the chromatin structure can serve as indirect activators. These compounds, by remodeling chromatin into a more open conformation, can facilitate the access of ZNF326 to its DNA-binding sites, thus potentiating its transcriptional impact. Furthermore, activators that modulate signaling pathways intersecting with ZNF326's activity can enhance its functional role. For instance, signaling molecules that activate pathways leading to the upregulation of specific co-factors of ZNF326 or that downregulate inhibitors of ZNF326 can increase the protein's transcriptional activity. These activators collectively enhance the ability of ZNF326 to perform its role as a transcription factor, orchestrating the expression of genes in a manner that reflects the fine-tuned balance of intracellular and extracellular stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly elevates intracellular cAMP levels, which can lead to the activation of PKA. Activated PKA may phosphorylate substrates that interact with ZNF326, enhancing its role in transcriptional regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can lead to DNA demethylation and the subsequent activation of certain genes. This process could increase the expression and functional activity of ZNF326. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which may result in a more relaxed chromatin structure and increased transcription of specific genes, potentially including those regulated by ZNF326. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can modulate various transcription factors and coactivators interacting with ZNF326, thereby enhancing its transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its receptors to regulate gene expression. It could enhance ZNF326 activity by promoting the transcription of genes that are co-regulated by ZNF326 and retinoic acid receptors. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG acts as an antioxidant and has been shown to affect transcription factors and signaling pathways. It may enhance ZNF326 activity by modulating pathways that ZNF326 is involved in, such as stress response pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a sirtuin activator that can influence gene expression. Its activation of sirtuins could lead to changes in chromatin structure, benefiting the transcriptional regulatory functions of ZNF326. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is an HDAC inhibitor that can lead to hyperacetylation of histones, potentially increasing the accessibility of transcriptional machinery to genes that ZNF326 regulates. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a cofactor for many DNA-binding proteins with zinc finger motifs, like ZNF326. Zinc sulfate can enhance the DNA binding activity of ZNF326, thus enhancing its functional role in gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 could lead to the activation of signaling pathways that upregulate transcription factors or coactivators working with ZNF326. | ||||||